268 related articles for article (PubMed ID: 12572870)
21. Decade in review-IBD: IBD-genes, bacteria and new therapeutic strategies.
Colombel JF
Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):652-4. PubMed ID: 25311475
[No Abstract] [Full Text] [Related]
22. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
[TBL] [Abstract][Full Text] [Related]
23. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
Schultz M; Schölmerich J; Rath HC
Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
[TBL] [Abstract][Full Text] [Related]
24. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
Wasilewski A; Zielińska M; Storr M; Fichna J
Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
[TBL] [Abstract][Full Text] [Related]
25. Probiotics and prebiotics in chronic inflammatory bowel diseases.
Ewaschuk JB; Dieleman LA
World J Gastroenterol; 2006 Oct; 12(37):5941-50. PubMed ID: 17009391
[TBL] [Abstract][Full Text] [Related]
26. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
Røseth AG; Aadland E; Grzyb K
Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345
[No Abstract] [Full Text] [Related]
27. Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease.
Sun J; Shen X; Li Y; Guo Z; Zhu W; Zuo L; Zhao J; Gu L; Gong J; Li J
Nutrients; 2016 Jan; 8(1):. PubMed ID: 26784223
[TBL] [Abstract][Full Text] [Related]
28. Antibiotics and probiotics in treatment of inflammatory bowel disease.
Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
[TBL] [Abstract][Full Text] [Related]
29. Probiotics, prebiotics and antibiotics in inflammatory bowel disease.
Cummings JH; Kong SC
Novartis Found Symp; 2004; 263():99-111; discussion 111-4, 211-8. PubMed ID: 15669637
[TBL] [Abstract][Full Text] [Related]
30. Probiotics in the Treatment of Inflammatory Bowel Disease.
Guandalini S; Sansotta N
Adv Exp Med Biol; 2019; 1125():101-107. PubMed ID: 30632114
[TBL] [Abstract][Full Text] [Related]
31. Diet therapy for inflammatory bowel diseases: The established and the new.
Durchschein F; Petritsch W; Hammer HF
World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283
[TBL] [Abstract][Full Text] [Related]
32. Utility of Escherichia coli Nissle in maintaining disease remission in inflammatory bowel disease.
Buldukoglu OC
J Gastrointestin Liver Dis; 2024 Jun; 33(2):280-281. PubMed ID: 38944860
[No Abstract] [Full Text] [Related]
33. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.
Rioux KP; Madsen KL; Fedorak RN
Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308
[No Abstract] [Full Text] [Related]
34. [Correction of intestinal microflora in patients with ulcerative colitis].
Kniazev OV
Eksp Klin Gastroenterol; 2011; (5):91-6. PubMed ID: 21916241
[No Abstract] [Full Text] [Related]
35. Role of probiotic therapy in IBD.
Isaacs K; Herfarth H
Inflamm Bowel Dis; 2008 Nov; 14(11):1597-605. PubMed ID: 18421762
[TBL] [Abstract][Full Text] [Related]
36. Classical and recent advances in the treatment of inflammatory bowel diseases.
Sales-Campos H; Basso PJ; Alves VB; Fonseca MT; Bonfá G; Nardini V; Cardoso CR
Braz J Med Biol Res; 2015 Feb; 48(2):96-107. PubMed ID: 25466162
[TBL] [Abstract][Full Text] [Related]
37. Probiotics in inflammatory bowel diseases and associated conditions.
Mack DR
Nutrients; 2011 Feb; 3(2):245-64. PubMed ID: 22254095
[TBL] [Abstract][Full Text] [Related]
38. Modification of intestinal flora in the treatment of inflammatory bowel disease.
Kanauchi O; Mitsuyama K; Araki Y; Andoh A
Curr Pharm Des; 2003; 9(4):333-46. PubMed ID: 12570821
[TBL] [Abstract][Full Text] [Related]
39. [Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease].
Marteau P; Seksik P
Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C94-7. PubMed ID: 11787388
[No Abstract] [Full Text] [Related]
40. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
Ganji-Arjenaki M; Rafieian-Kopaei M
J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
